JS

Jayaram Sale

Active Director Director DIN 08988817
DIN 08988817 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Jayaram Sale

Data last updated:

Jayaram Sale is a Director at Rex Genia Life Sciences Private Limited (since 2020). The company operates in Pharma. Rex Genia Life Sciences Private Limited reported revenue of ₹3.71 Cr (FY 2025).

DIN 08988817
Primary Designation Director
Industry Pharma
First Appointment 09 Dec 2020
Oldest Company Age 10 yrs
Largest company Rex Genia Life Sciences Private Limited · ₹3.71 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Dec 20202016₹3.71 Cr (FY 2025)Active

Board colleagues of Jayaram Sale

Directorship timeline

Open interactive timeline →
Rex Genia Life Sciences Private Limited
Premium access

Shareholding and investment profile for Jayaram Sale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayaram Sale

Jayaram Sale currently holds 1 directorship: Rex Genia Life Sciences Private Limited (Director, since 09 Dec 2020, revenue ₹3.71 Cr (FY 2025)).

Jayaram Sale was first appointed on 09 Dec 2020 as Director at Rex Genia Life Sciences Private Limited.

The current boards of Jayaram Sale's companies include Kurva Joshi Raghavendraprasad (Rex Genia Life Sciences Private Limited), Parvatamma Basapuram (Rex Genia Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available